| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 24, 2014
HeartWare International, Inc. (Nasdaq: HTWR) today announced issuance of a clinician and patient reminder concerning the Urgent Medical Device Correction distributed to all of its clinical sites...
-
May 21, 2014Rigorous Two-Year Analyses Presented at EuroPCR 2014 Affirm Safety, Efficacy and Sustained Valve Performance of Self-Expanding Valve
PARIS and MINNEAPOLIS - May 21, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed new data showing that patients treated with the CoreValve® System experienced positive clinical outcomes in the...
-
May 21, 2014ILLUMENATE First-in-Human Clinical Trial Supports the Stellarex™ Balloon with EnduraCoat™ Technology in Treating Peripheral Arterial Disease
PARIS--(BUSINESS WIRE)--May 22, 2014-- Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial...
-
May 20, 2014Q4 Revenue of $4.6 Billion Grew 3% at Constant Currency; 2% as Reported
MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2014, which ended April 25, 2014. The company reported worldwide...
-
May 20, 2014Noncompliant Balloon Provides Superior Deliverability and Controlled Growth for Challenging Coronary Angioplasty Procedures
MINNEAPOLIS -- May 20, 2014 -- Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité
-
May 13, 2014
MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, May 20, 2014. A news release will...
-
May 10, 2014Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...
-
May 10, 2014MINERVA Trial Presented at Heart Rhythm Meeting Shows Medtronic Advanced Pacing Features Reduce the Progression of Persistent AF by 58 Percent While Reducing AF-Related Hospital Visits That Lead to Increased Healthcare Costs
MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing...
-
May 9, 2014
MINNEAPOLIS - May 9, 2014 - Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Thursday, June 5, 2014, in New York City from 8:30 a.m. to approximately 1:00 p.m....
-
May 1, 2014
HeartWare International, Inc. (Nasdaq: HTWR), today issued a voluntary Urgent Medical Device Correction related to all HeartWare® Ventricular Assist System batteries, product codes 1650 and...